Nacubactam

DB15353InvestigationalSmall molecule

Nacubactam is under investigation in clinical trial NCT03174795 (A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection).

Chemical structure of Nacubactam
Formula / weight
C9H16N4O7S · 324.31 g/mol (avg)
Code names
RO7079901

Resolves to

Compound
UNII832O37V7MZCAS1452458-86-4ChEMBLCHEMBL3989959
Structure
InChIKeyRSBPYSTVZQAADE-RQJHMYQMSA-NSMILESNCCONC(=O)[C@@H]1CC[C@@H]2C[N@]1C(=O)N2OS(O)(=O)=O
Targets
P00807blaZ

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Nacubactam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In